Insulin and Injectable Therapy Posters and Abstracts from New Orleans

Source: American Diabetes Association 76th Scientific Sessions held June 10-14, 2016, New Orleans, Louisiana.

Overview

Mayer Davidson, MD and Vivian Fonseca, MD provide their perspectives on key posters and abstracts on management of patients with type 1 and type 2 diabetes mellitus with insulin and injectable therapies.

Listen to summaries of 11 posters presented at the meeting.

Proceed at your own pace and in any order. Each poster perspective is about 5 minutes.

Compare your knowledge against your peers.

Download summary slides to your library.

Content Areas

This activity was developed for endocrinologists, primary care physicians, and other health care professionals who treat patients with type 1 and type 2 diabetes.

  • AWARD 9, LEADER, ONSET 1, ONSET 2, SUSTAIN 3
  • GLP-1 receptor agonists
  • Faster-acting insulin aspart and insulin degludec
  • Basal insulin/GLP-1 receptor agonist fixed combination
  • Hypoglycemia
  • β-cell function

This activity is supported by educational funding provided by Novo Nordisk Inc.

Faculty

Mayer Davidson, MD

Mayer Davidson, MD

Professor of Medicine
Charles R. Drew University
David Geffen School of Medicine at UCLA
Los Angeles, California
Vivian Andrew Fonseca, MD, FRCP

Vivian Andrew Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Tullis – Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology and Metabolism
Tulane University Health Sciences Center
New Orleans, Louisiana
Enter your information to begin.
CME Credit
Available Credit: 2.50 AMA PRA Category 1 Credits™
Opens: July 22, 2016
Expires: July 21, 2017
Target Audience Endocrinologists
Primary Care Physicians
Other Health Care Professionals